Federal court dismisses criminal indictment against Cassava's former collaborator Dr. Wang

FILANA THERAPEUTICS, INC.

U.S. District Court for Maryland granted unopposed motion to dismiss with prejudice all charges against Dr. Hoau-Yan Wang.
Charges had accused Dr. Wang of causing false grant applications and fabricating research results including Western Blot images.
Dismissal permanently terminates the case; no future charges can be refiled.
Company reaffirms its simufilam program for TSC-related epilepsy based on research at multiple institutions.
Cassava states support for integrity in scientific research and distances from the dismissed allegations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.